Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
A randomized, double- blind, placebo- controlled study of the lowest effective dose of drospirenone with 17 beta- estradiol for moderate to severe vasomotor symptoms in postmenopausal women
Article
Overview
Research
Additional Document Info
View All
Overview
sustainable development goals
SDG 03: Good Health and Well-being
SDG 05: Gender Equality
authors
Archer, David F.
publication date
March 1, 2014
webpage
Web of Science
published in
MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY
Journal
Research
keywords
17-Estradiol
Drospirenone
Hot flushes
Postmenopausal women
Vasomotor symptoms
Additional Document Info
start page
227
end page
235
volume
21
issue
3